Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Mayes

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Environmental Health Perspectives|September 30, 1999
Epidemiologic studies of environmental agents and systemic autoimmune diseasesM D Mayes
Rheumatic Diseases Clinics of North America|February 19, 2000
Photopheresis and autoimmune diseasesM D Mayes
Seminars in Cutaneous Medicine and Surgery|March 25, 1998
Classification and epidemiology of sclerodermaM D Mayes
Rheumatic Diseases Clinics of North America|November 1, 1996
Scleroderma epidemiologyM D Mayes
Current Rheumatology Reports|December 21, 2000
The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosisM D Mayes
Current Opinion in Rheumatology|February 12, 1998
Epidemiology of systemic sclerosis and related diseasesM D Mayes
Biochemical and Biophysical Research Communications|March 20, 1999
IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell deathT Z Kirk, M D Mayes
Arthritis and Rheumatism|July 1, 1996
Familial aggregation of primary Raynaud's diseaseR R Freedman, M D Mayes
The Journal of Rheumatology|November 11, 1999
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and sclerodermaR R Freedman, R Girgis, M D Mayes
Lancet (London, England)|September 4, 1999
Acute effect of nitric oxide on Raynaud's phenomenon in sclerodermaR R Freedman, R Girgis, M D Mayes
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Environmental Health Perspectives|September 30, 1999
Epidemiologic studies of environmental agents and systemic autoimmune diseasesM D Mayes
Rheumatic Diseases Clinics of North America|February 19, 2000
Photopheresis and autoimmune diseasesM D Mayes
Seminars in Cutaneous Medicine and Surgery|March 25, 1998
Classification and epidemiology of sclerodermaM D Mayes
Rheumatic Diseases Clinics of North America|November 1, 1996
Scleroderma epidemiologyM D Mayes
Current Rheumatology Reports|December 21, 2000
The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosisM D Mayes
Current Opinion in Rheumatology|February 12, 1998
Epidemiology of systemic sclerosis and related diseasesM D Mayes
Biochemical and Biophysical Research Communications|March 20, 1999
IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell deathT Z Kirk, M D Mayes
Arthritis and Rheumatism|July 1, 1996
Familial aggregation of primary Raynaud's diseaseR R Freedman, M D Mayes
The Journal of Rheumatology|November 11, 1999
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and sclerodermaR R Freedman, R Girgis, M D Mayes
Lancet (London, England)|September 4, 1999
Acute effect of nitric oxide on Raynaud's phenomenon in sclerodermaR R Freedman, R Girgis, M D Mayes
Pageof 6